Optimized tablet formulation

Details Optimized tablet formulation Optimized tablet formulation

A - Human Necessities

61

K

A61K 31/415 (2006.01) A61K 9/20 (2006.01)

Patent

CA 2067307

0597H/6052A 18319 TITLE OF THE INVENTION OPTIMIZED TABLET FORMULATION ABSTRACT OF THE DISCLOSURE An optimized direct compression tablet formulation comprises in parts by weight from about 10% to about 45% of 2-butyl-4-chloro-1[(2'(1H- tetrazol-5-yl)biphenyl-4-yl)methyl]-5-(hydroxymethyl)- imidazole, from about 20% to about 40% microcrystal- line cellulose, from about 10% to about 30% lactose, from about 0.5% to about 0.9% magnesium stearate, and from about 5% to about 35% pregel starch.

Affiliated with

Also associated with

Rating

Optimized tablet formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Optimized tablet formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Optimized tablet formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1432903